Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (KRYS)
CUSIP: 501147102
Q3 2018 13F Holders as of 30 Sep 2018
- Type / Class
- Equity / Common Stock, $0.00001 par value ("Common Stock")
- Shares outstanding
- 29,463,330
- Total 13F shares
- 2,717,290
- Share change
- +327,046
- Total reported value
- $47,597,000
- Price per share
- $17.58
- Number of holders
- 21
- Value change
- +$6,006,830
- Number of buys
- 13
- Number of sells
- 6
Quarterly Holders Quick Answers
What is CUSIP 501147102?
CUSIP 501147102 identifies KRYS - Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 501147102:
Top shareholders of KRYS - Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
4.1%
|
1,200,000
|
$17,844,000 | — | 30 Jun 2018 | |
| Knoll Capital Management, LLC |
13F
|
Company |
1%
|
300,000
|
$4,461,000 | — | 30 Jun 2018 | |
| Tourbillon Capital Partners, L.P. |
13F
|
Company |
0.7%
|
205,236
|
$3,052,000 | — | 30 Jun 2018 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.68%
|
200,000
|
$2,974,000 | — | 30 Jun 2018 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.52%
|
153,378
|
$2,281,000 | — | 30 Jun 2018 | |
| Artal Group S.A. |
13F
|
Company |
0.51%
|
150,000
|
$2,231,000 | — | 30 Jun 2018 | |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.23%
|
68,959
|
$1,025,000 | — | 30 Jun 2018 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.12%
|
36,466
|
$542,000 | — | 30 Jun 2018 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.09%
|
25,764
|
$383,000 | — | 30 Jun 2018 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.07%
|
21,378
|
$318,000 | — | 30 Jun 2018 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.04%
|
13,040
|
$194,000 | — | 30 Jun 2018 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.04%
|
12,202
|
$182,000 | — | 30 Jun 2018 | |
| KBC Group NV |
13F
|
Company |
0.01%
|
2,225
|
$33,000 | — | 30 Jun 2018 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
1,196
|
$18,000 | — | 30 Jun 2018 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
300
|
$4,000 | — | 30 Jun 2018 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0%
|
100
|
$1,000 | — | 30 Jun 2018 | |
| THOMPSON DAVIS & CO., INC. |
13F
|
Company |
0%
|
100
|
$1,000 | — | 30 Jun 2018 |
Institutional Holders of Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (KRYS) as of Q3 2018
As of 30 Sep 2018,
Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (KRYS) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,717,290 shares.
The largest 10 holders included
FMR LLC, FRAZIER MANAGEMENT LLC, Knoll Capital Management, LP, Vanguard Group Inc, Artal Group S.A., Tourbillon Capital Partners, L.P., BAKER BROS. ADVISORS LP, S Squared Technology, LLC, RENAISSANCE TECHNOLOGIES LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
21
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2018 vs Q2 2018 Across Filers
Q2 2018 holders
16
Q3 2018 holders
21
Holder diff
5
| Investor | Q2 2018 Shares | Q3 2018 Shares | Share Diff | Share Chg % | Q2 2018 Value $ | Q3 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.